Alfavision Overseas (India) Limited
BSE: ALFAVIO
Prev Close
12.6
Open Price
12.29
Volume
3,062
Today Low / High
12.29 / 12.78
52 WK Low / High
11.79 / 16.66
Range
12 - 13
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 12.57, reflecting a change of -0.03 (-0.2381%). The expected target range on the BSE is 12 - 13. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Alfavision Overseas (India) Limited Graph
Alfavision Overseas (India) Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Alfavision Overseas (India) Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 12.57, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
Scenario | Price | Target | Range |
---|---|---|---|
Bullish Scenario | 12.57 | 12.70 | 11.43 - 13.97 |
12.82 | 10.26 - 15.39 | ||
12.95 | 9.06 - 16.83 | ||
Bearish Scenario | 12.57 | 12.44 | 11.20 - 13.69 |
12.32 | 9.85 - 14.78 | ||
12.19 | 8.54 - 15.85 |
Overview of Alfavision Overseas (India) Limited
ISIN
INE883B01027
Industry
Biotechnology
Vol.Avg
17,701
Market Cap
396,281,820
Last Dividend
0
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Stock Dividend of ALFAVIO
Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|---|
2022-09-29 | September 29, 22 | 0.05 | 0.05 | 2022-09-29 | 2022-10-30 | |
2021-09-22 | September 22, 21 | 0.02 | 0.2 | 2021-09-23 | 2021-10-30 |
Annual Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-31 | 3.13 Cr | 2.08 Cr | 1.05 Cr | 0.3345 | 0.00 Cr | 0.03 Cr | 0.93 Cr | 0.28 Cr | 0.09 | 1.01 Cr | 0.0884 |
2023-03-31 | 58.58 Cr | 55.43 Cr | 3.15 Cr | 0.0538 | 0.00 Cr | 0.07 Cr | 2.59 Cr | -2.16 Cr | -0.69 | 2.28 Cr | -0.0370 |
2022-03-31 | 181.57 Cr | 175.72 Cr | 5.85 Cr | 0.0322 | 0.00 Cr | 0.18 Cr | 4.84 Cr | 2.01 Cr | 0.64 | 6.16 Cr | 0.0111 |
2021-03-31 | 179.10 Cr | 173.35 Cr | 5.74 Cr | 0.0321 | 0.00 Cr | 0.09 Cr | 3.91 Cr | 1.49 Cr | 0.44 | 4.93 Cr | 0.0083 |
2020-03-31 | 156.98 Cr | 152.81 Cr | 4.17 Cr | 0.0265 | 0.00 Cr | 0.23 Cr | 3.26 Cr | 0.09 Cr | 0.05 | 3.33 Cr | 0.0005 |
Annual Financials Balance Sheet
Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-31 | 0.17 Cr | 178.56 Cr | 136.59 Cr | 41.9709 Cr | 124.36 Cr | 124.19 Cr | 0.00 Cr | 30.27 Cr | 0.00 Cr | 0.00 Cr | 0.62 Cr | 0.8783 Cr |
2023-03-31 | 0.13 Cr | 204.84 Cr | 161.56 Cr | 43.2760 Cr | 156.53 Cr | 156.40 Cr | 4.93 Cr | 30.35 Cr | 1.09 Cr | 0.00 Cr | 0.00 Cr | 5.0447 Cr |
2022-03-31 | 0.91 Cr | 316.88 Cr | 271.27 Cr | 45.6012 Cr | 143.15 Cr | 142.24 Cr | 1.05 Cr | 30.38 Cr | 0.05 Cr | 0.00 Cr | 104.09 Cr | 142.0078 Cr |
2021-03-31 | 0.21 Cr | 115.44 Cr | 101.92 Cr | 13.5136 Cr | 54.72 Cr | 54.52 Cr | 0.58 Cr | 0.48 Cr | 1.50 Cr | 0.00 Cr | 9.02 Cr | 77.6370 Cr |
2020-03-31 | 0.58 Cr | 101.16 Cr | 89.14 Cr | 8.4472 Cr | 49.16 Cr | 48.58 Cr | 9.15 Cr | 0.46 Cr | 0.32 Cr | 0.00 Cr | 0.00 Cr | 69.1161 Cr |
Annual Financials Cash Flow Statement
Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-31 | -9.7203 Cr | 1.1312 Cr | 8.6426 Cr | -9.7251 Cr | 0.0535 Cr | 0.1705 Cr | 0.0000 Cr | 0.2764 Cr | 9.3420 Cr | 0.0000 Cr | 0.0000 Cr |
2023-03-31 | 2.5515 Cr | -16.0073 Cr | 12.6783 Cr | 2.5325 Cr | -0.7775 Cr | 0.1330 Cr | -0.0190 Cr | -2.1531 Cr | 15.6156 Cr | -0.1634 Cr | 1.0461 Cr |
2022-03-31 | -2.7054 Cr | -81.7441 Cr | 85.1528 Cr | -2.7054 Cr | 0.7033 Cr | 0.9105 Cr | 0.0000 Cr | 2.1290 Cr | 89.0728 Cr | 0.0000 Cr | -0.4633 Cr |
2021-03-31 | -2.6288 Cr | -0.1726 Cr | 2.4290 Cr | -2.8028 Cr | -0.3724 Cr | 0.2072 Cr | -0.1740 Cr | 1.6925 Cr | 5.5711 Cr | 0.0000 Cr | -0.5827 Cr |
2020-03-31 | -16.9856 Cr | 0.4188 Cr | 16.8048 Cr | -17.0557 Cr | 0.2380 Cr | 0.5796 Cr | -0.0701 Cr | 0.2595 Cr | 19.7894 Cr | 0.0000 Cr | 0.0000 Cr |
Quarterly Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|
2024-12-31 | 0.49 Cr | 0.44 Cr | 0.05 Cr | 0.1096 | 0.00 Cr | 0.01 Cr | 0.00 | 0.02 Cr | 0.0252 |
2024-09-30 | 0.44 Cr | 0.27 Cr | 0.18 Cr | 0.4023 | 0.12 Cr | 0.12 Cr | 0.04 | 0.13 Cr | 0.2735 |
2024-06-30 | 0.97 Cr | 0.83 Cr | 0.14 Cr | 0.1418 | 0.09 Cr | 0.09 Cr | 0.03 | 0.10 Cr | 0.0892 |
2024-03-31 | 0.11 Cr | 0.89 Cr | -0.79 Cr | -7.4929 | -0.81 Cr | 0.10 Cr | 0.03 | -0.65 Cr | 0.9696 |
2023-12-31 | 1.22 Cr | 0.48 Cr | 0.74 Cr | 0.6039 | -0.07 Cr | -0.59 Cr | -0.19 | -0.06 Cr | -0.4808 |
Quarterly Financials Balance Sheet
Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
---|---|---|---|---|---|---|---|---|---|
2024-09-30 | 0.17 Cr | 0.24 Cr | 0.40 Cr | 0.00 Cr | 0.00 Cr | 27.63 Cr | 30.25 Cr | 178.89 Cr | 136.71 Cr |
2024-03-31 | 0.17 Cr | 0.00 Cr | 0.17 Cr | 27.12 Cr | 0.00 Cr | 27.29 Cr | 30.27 Cr | 178.56 Cr | 136.59 Cr |
2023-12-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2023-09-30 | 0.23 Cr | 0.26 Cr | 0.49 Cr | 18.13 Cr | -0.26 Cr | 18.62 Cr | 30.29 Cr | 169.86 Cr | 127.43 Cr |
2023-06-30 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Quarterly Financials Cash Flow Statement
Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|
2023-12-31 | -0.59 Cr | 0.02 Cr | 0.00 Cr | 0.00 Cr | 0.02 Cr | 0.25 Cr | 0.23 Cr | 0.00 Cr | 0.02 Cr |
2023-09-30 | 0.01 Cr | 0.01 Cr | 0.00 Cr | 0.00 Cr | 0.01 Cr | 0.23 Cr | 0.22 Cr | 0.00 Cr | 0.01 Cr |
2023-06-30 | 0.73 Cr | 0.73 Cr | 0.00 Cr | 0.00 Cr | 0.60 Cr | 0.73 Cr | 0.13 Cr | 0.00 Cr | 0.73 Cr |
2023-03-31 | -3.20 Cr | -3.20 Cr | 0.00 Cr | 0.00 Cr | -3.20 Cr | 0.13 Cr | 3.34 Cr | 0.00 Cr | -3.20 Cr |
2022-12-31 | -0.50 Cr | -0.50 Cr | 0.00 Cr | 0.00 Cr | -0.75 Cr | -0.50 Cr | 0.25 Cr | 0.00 Cr | -0.50 Cr |
Splits History
Date | Label | Split Ratio |
---|---|---|
2022-08-29 | August 29, 22 | 10:1 |
Similar Stocks: Biotechnology
Company Name | Symbol | Price | Market Cap | Volume |
---|---|---|---|---|
Biocon Limited | BIOCON | ₹326.75 | ₹392,296,050,000.00 | ₹4,710,121.00 |
Piramal Pharma Limited | PPLPHARMA | ₹219.87 | ₹291,492,256,734.00 | ₹4,921,475.00 |
Syngene International Limited | SYNGENE | ₹653.40 | ₹262,205,044,180.00 | ₹20,241,141.00 |
Concord Biotech Limited | CONCORDBIO | ₹1,650.70 | ₹172,689,961,340.00 | ₹134,572.00 |
Blue Jet Healthcare Limited | BLUEJET | ₹764.45 | ₹132,605,640,319.00 | ₹617,536.00 |
Jubilant Ingrevia Limited | JUBLINGREA | ₹680.05 | ₹108,319,044,050.00 | ₹150,629.00 |
Supriya Lifescience Limited | SUPRIYA | ₹706.60 | ₹56,869,146,480.00 | ₹226,643.00 |
Dishman Carbogen Amcis Limited | DCAL | ₹215.43 | ₹33,775,761,690.00 | ₹492,057.00 |
Panacea Biotec Limited | PANACEABIO | ₹538.35 | ₹32,974,338,032.00 | ₹564,389.00 |
Zota Health Care Limited | ZOTA | ₹883.30 | ₹24,628,640,516.00 | ₹37,596.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born: 1965
Gender: male
Year Born: 1991
FAQs about Alfavision Overseas (India) Limited
The CEO is Mr. Vishnu Prasad Goyal.
The current price is ₹12.57.
The range is ₹11.79-16.66.
The market capitalization is ₹39.63 crores.
The P/E ratio is 122.88.
The company operates in the Healthcare sector.
Overview of Alfavision Overseas (India) Limited (ISIN: INE883B01027) is a leading Biotechnology in India. With a market capitalization of ₹39.63 crores and an average daily volume of 17,701 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.